Saturday, August 9, 2025

Lululemon: Q1 2021 Consensus Analyst Estimates

Lululemon (NASDAQ: LULU) will be reporting their first quarter financial results on June 3rd after market close. Analysts have a consensus $385.25 12-month price target on the company, via a total of 33 analysts, with eight analysts having strong buy ratings, 14 analysts having buy ratings, and 11 analysts have a hold rating. The street high comes in at a $465 price target from Piper Sandler, and the lowest target sits at $275.

25 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 25 analysts is $1.122 billion; this number has been revised upwards from $983.79 million at the start of the year. The highest revenue estimate is $1.17 billion, while the lowest is $1.005 billion.

The analyst consensus for net income for the first quarter is $117.19 million, this is up from the start of the year at $104.60 million. The highest net income estimate is $122 million, while the lowest is $113 million.

Onto EBITDA estimates, there are currently 11 analysts who have first quarter EBITDA estimates. The mean is currently $202.34 million, with this number having been revised higher from $183.37 million at the start of the year. The street high estimate currently sits at $235.45 million in EBITDA and the lowest is $143.7 million.

Analysts estimate that quarterly earnings per share will come in at $0.90, with this number being slightly higher from the $0.82 estimate at the start of the year. The street high is $0.91 and the lowest estimate is $0.85 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Tesla: Canaccord Doubles Price Target To $1,071

On Monday, one of the more bearish Tesla Inc. (NASDAQ: TSLA) analysts flipped bullish, and...

Tuesday, April 13, 2021, 11:41:00 AM

Ayr Strategies: PI Financial Initiates With $60 Price Target, Buy Rating

On January 20th, PI Financial became the fourth firm to cover Ayr Strategies’ (CSE: AYR.a)....

Sunday, January 24, 2021, 11:34:00 AM

MicroStrategy: Canaccord Lowers Price Target To $780

MicroStrategy (NASDAQ: MSTR) reported its second quarter financial results on July 29. The company reported...

Tuesday, August 3, 2021, 11:35:00 AM

Canaccord: “We Believe The Fundamentals Of Lundin Mining Remain Strong”

This morning, Cannacord Genuity reiterated their C$11 price target and Buy rating on Lundin Mining...

Friday, October 30, 2020, 01:49:00 PM

Facebook: BMO Anticipates Several Headwinds To Hit Top Line

On October 25th, Facebook (NASDAQ: FB), now called Meta Platforms, reported their 2021 third quarter...

Monday, November 1, 2021, 02:56:00 PM